NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,211 | +0.9% | 4,361 | 0.0% | 0.07% | +3.1% |
| Q2 2023 | $440,069 | -16.6% | 4,361 | -24.0% | 0.06% | -20.7% |
| Q1 2023 | $527,620 | -0.3% | 5,735 | -1.7% | 0.08% | -3.5% |
| Q4 2022 | $529,351 | +12.2% | 5,835 | -6.1% | 0.08% | +1.2% |
| Q3 2022 | $472,000 | -10.1% | 6,215 | 0.0% | 0.08% | -7.7% |
| Q2 2022 | $525,000 | -3.8% | 6,215 | -0.1% | 0.09% | +7.1% |
| Q1 2022 | $546,000 | +2.4% | 6,220 | +2.1% | 0.08% | +2.4% |
| Q4 2021 | $533,000 | +11.7% | 6,095 | +4.5% | 0.08% | +1.2% |
| Q3 2021 | $477,000 | -10.3% | 5,835 | 0.0% | 0.08% | -9.9% |
| Q2 2021 | $532,000 | +20.4% | 5,835 | +12.8% | 0.09% | +9.6% |
| Q1 2021 | $442,000 | -6.9% | 5,172 | +2.9% | 0.08% | -13.5% |
| Q4 2020 | $475,000 | +129.5% | 5,027 | +111.0% | 0.10% | +95.9% |
| Q3 2020 | $207,000 | -99.8% | 2,382 | +120.6% | 0.05% | -46.2% |
| Q4 2017 | $90,677,000 | – | 1,080 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |